Ameritas Investment Partners, Inc. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 105 filers reported holding ANTARES PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$58,000
+13.7%
14,2090.0%0.00%0.0%
Q4 2021$51,000
-1.9%
14,2090.0%0.00%0.0%
Q3 2021$52,000
-16.1%
14,2090.0%0.00%0.0%
Q2 2021$62,000
+6.9%
14,2090.0%0.00%0.0%
Q1 2021$58,000
+1.8%
14,2090.0%0.00%
-33.3%
Q4 2020$57,000
+50.0%
14,2090.0%0.00%
+50.0%
Q3 2020$38,000
-2.6%
14,2090.0%0.00%0.0%
Q2 2020$39,000
+14.7%
14,2090.0%0.00%0.0%
Q1 2020$34,000
-49.3%
14,2090.0%0.00%
-33.3%
Q4 2019$67,000
+59.5%
14,209
+12.7%
0.00%
+50.0%
Q3 2019$42,000
+2.4%
12,6120.0%0.00%0.0%
Q2 2019$41,000
+7.9%
12,6120.0%0.00%0.0%
Q1 2019$38,000
+11.8%
12,6120.0%0.00%0.0%
Q4 2018$34,000
-19.0%
12,6120.0%0.00%0.0%
Q3 2018$42,000
+27.3%
12,6120.0%0.00%0.0%
Q2 2018$33,000
+17.9%
12,6120.0%0.00%
+100.0%
Q1 2018$28,000
+12.0%
12,6120.0%0.00%0.0%
Q4 2017$25,000
-32.4%
12,6120.0%0.00%
-50.0%
Q3 2017$37,000
-9.8%
12,6120.0%0.00%0.0%
Q2 2017$41,00012,6120.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders